<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
GALT
Galectin Therapeutics
$
()


  • Galectin Therapeutics says DSMB recommends continuation of NAVIGATE study

    4/9/2024 - 08:08am
  • Biotech Alert: Searches spiking for these stocks today

    4/5/2024 - 10:40am
  • Galectin Therapeutics appoints Khurram Jamil as VP, clinical development

    3/12/2024 - 08:10am
  • Galectin Therapeutics expects cash to fund operations through December 2024

    11/13/2023 - 08:03am
  • Galectin Therapeutics reports Q3 EPS (24c) vs. (14c) last year

    11/13/2023 - 08:02am
  • Galectin Therapeutics nominates Benjamin Carson to board of directors

    10/12/2023 - 08:07am
  • Galectin Therapeutics reports DSMB concludes NAVIGATE can continue as designed

    10/3/2023 - 08:13am
  • Galectin Therapeutics to present update on belapectin liver cirrhosis program

    9/26/2023 - 08:23am
  • Galectin Therapeutics to present data on liver cirrhosis at NASH meeting

    9/7/2023 - 12:04pm
  • Galectin Therapeutics reports Q2 EPS (15c) vs (16c) last year

    8/14/2023 - 08:12am
  • Galectin Therapeutics reports Q4 EPS (19c) vs (17c) last year

    5/15/2023 - 08:12am
dynamic_feed Breaking News